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Abstract:	  1 Many	  bacterial	  species	  are	  composed	  of	  multiple	  lineages	  distinguished	  by	  extensive	  2 variation	  in	  gene	  content.	  These	  often	  co-­‐circulate	  in	  the	  same	  habitat,	  but	  the	  evolutionary	  3 and	  ecological	  processes	  that	  shape	  these	  complex	  populations	  are	  poorly	  understood.	  4 Addressing	  these	  questions	  is	  particularly	  important	  for	  Streptococcus	  pneumoniae,	  a	  5 nasopharyngeal	  commensal	  and	  respiratory	  pathogen,	  as	  the	  changes	  in	  population	  6 structure	  associated	  with	  the	  recent	  introduction	  of	  partial-­‐coverage	  vaccines	  have	  7 significantly	  reduced	  pneumococcal	  disease.	  Here	  we	  show	  pneumococcal	  lineages	  from	  8 multiple	  populations	  each	  have	  a	  distinct	  combination	  of	  intermediate	  frequency	  genes.	  9 Functional	  analysis	  suggested	  these	  loci	  were	  likely	  subject	  to	  negative	  frequency-­‐10 dependent	  selection	  (NFDS)	  through	  interactions	  with	  other	  bacteria,	  hosts,	  or	  mobile	  11 elements.	  Correspondingly,	  these	  genes	  had	  similar	  frequencies	  in	  four	  populations	  with	  12 dissimilar	  lineage	  compositions.	  These	  frequencies	  were	  maintained	  following	  substantial	  13 alterations	  in	  lineage	  prevalences	  once	  vaccination	  programmes	  began.	  Fitting	  a	  multilocus	  14 NFDS	  model	  of	  post-­‐vaccine	  population	  dynamics	  to	  three	  genomic	  datasets	  using	  15 Approximate	  Bayesian	  Computation	  generated	  reproducible	  estimates	  of	  the	  influence	  of	  16 NFDS	  on	  pneumococcal	  evolution,	  the	  strength	  of	  which	  varied	  between	  loci.	  Simulations	  17 replicated	  the	  stable	  frequency	  of	  lineages	  unperturbed	  by	  vaccination,	  patterns	  of	  serotype	  18 switching,	  and	  clonal	  replacement.	  This	  framework	  highlights	  how	  bacterial	  ecology	  affects	  19 the	  impact	  of	  clinical	  interventions.	   	  20 
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Population	  genomics	  has	  revealed	  many	  bacterial	  species	  exhibit	  extensive	  variation	  in	  1 their	  ‘accessory’	  genomes.	  While	  neutral	  evolutionary	  models	  can	  account	  for	  such	  2 diversity1–3,	  allowing	  for	  heterogeneity	  in	  the	  evolutionary	  rate	  between	  genes	  significantly	  3 improves	  their	  fit	  to	  genomic	  data4–6,	  consistent	  with	  selection	  causing	  differences	  in	  gene	  4 content7.	  If	  recombination	  rates	  are	  sufficiently	  high,	  selection	  can	  alter	  the	  distribution	  of	  5 individual	  genes8.	  However,	  lower	  levels	  of	  recombination	  are	  associated	  with	  6 chromosome-­‐wide	  sweeps,	  such	  that	  niche	  specialization	  at	  one	  or	  more	  loci	  can	  result	  in	  7 largely	  clonal	  ‘ecotypes’9,10.	  Similarly,	  a	  recent	  model	  suggested	  selection	  acting	  on	  a	  high	  8 proportion	  of	  the	  genome	  could	  partition	  even	  freely-­‐recombining	  bacteria	  into	  highly-­‐9 diverged	  ‘metabolic	  types’11.	  As	  well	  as	  adaptation	  to	  particular	  niches,	  this	  latter	  model11	  10 considered	  antigenic	  loci	  to	  be	  under	  negative	  frequency-­‐dependent	  selection	  (NFDS),	  the	  11 situation	  in	  which	  alleles	  are	  most	  beneficial	  to	  genotypes	  when	  they	  are	  rare.	  This	  is	  based	  12 on	  the	  assumption	  antigens	  become	  more	  costly	  when	  common,	  because	  they	  are	  more	  13 frequently	  recognised	  by	  acquired	  immune	  responses.	  	  14 	  15 Such	  NFDS	  has	  been	  proposed	  to	  explain	  the	  extensive	  antigenic	  diversity	  of	  the	  16 nasopharyngeal	  coloniser	  and	  respiratory	  pathogen	  Streptococcus	  pneumoniae	  (the	  17 pneumococcus)11–13.	  This	  variation	  makes	  anti-­‐pneumococcal	  vaccine	  development	  18 challenging.	  The	  first	  licensed	  conjugate	  vaccine	  (PCV7)	  targeted	  seven	  of	  over	  ninety	  19 serotypes14,	  and	  consequently	  was	  associated	  with	  ‘serotype	  replacement’	  as	  vaccine	  types	  20 (VTs)	  were	  replaced	  by	  non-­‐vaccine	  types	  (NVTs),	  with	  no	  overall	  change	  in	  carriage	  21 rates15.	  This	  was	  driven	  by	  both	  serotype	  switching,	  the	  replacement	  of	  VTs	  by	  NVTs	  that	  22 differed	  at	  few	  loci	  other	  than	  that	  which	  determined	  the	  serotype,	  and	  clonal	  replacement	  23 of	  VTs	  by	  distantly-­‐related	  NVTs.	  These	  population	  dynamics	  are	  now	  amenable	  to	  detailed	  24 study,	  having	  been	  tracked	  by	  genomic	  surveillance	  of	  isolates	  carried	  by	  children	  in	  both	  25 Massachusetts	  (USA)	  14	  and	  Southampton	  (UK)	  16,17,	  and	  isolates	  from	  invasive	  26 
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pneumococcal	  disease	  in	  adults	  in	  Nijmegen	  (the	  Netherlands)	  18.	  Here	  we	  use	  the	  1 distribution	  of	  the	  accessory	  genome	  across	  isolates	  to	  develop	  a	  gene	  frequency-­‐based	  2 model	  of	  bacterial	  population	  structure	  based	  on	  multiple	  NFDS	  mechanisms19,20.	  3 	  4 
Results	  5 	  6 
Enrichment	  of	  loci	  under	  frequency-­‐dependent	  selection	  in	  the	  accessory	  genome	  7 Previous	  analyses	  of	  5,442	  clusters	  of	  orthologous	  genes	  (COGs)	  in	  the	  Massachusetts	  8 pneumococcal	  population	  suggested	  those	  present	  at	  intermediate	  frequencies	  were	  9 important	  in	  distinguishing	  sequence	  clusters21.	  To	  identify	  functions	  that	  were	  enriched	  in	  10 this	  set	  of	  genes,	  the	  1,112	  COGs	  present	  in	  5%	  to	  95%	  of	  isolates	  and	  1,194	  core	  COGs14	  11 were	  annotated	  by	  integrating	  multiple	  analyses	  (Fig	  1a	  &	  Supplementary	  Datasets	  1	  and	  12 2).	  The	  most	  substantive	  difference	  was	  in	  mobile	  genetic	  elements	  (MGEs;	  Fisher’s	  exact	  13 test;	  odds	  ratio,	  OR	  =	  336;	  two-­‐sided	  p	  <	  2.2x10-­‐16).	  However,	  few	  of	  these	  genes	  were	  14 ‘cargo’	  beneficial	  to	  the	  host	  bacterium,	  and	  were	  instead	  likely	  to	  be	  parasitic,	  consistent	  15 with	  the	  distribution	  of	  prophage	  between	  pneumococci21,22.	  Correspondingly,	  restriction	  16 modification	  systems	  (RMSs)	  that	  protect	  against	  MGE	  infection	  accounted	  for	  2.4%	  of	  the	  17 intermediate-­‐frequency	  genes,	  but	  were	  absent	  from	  the	  core	  COGs.	  These	  are	  most	  often	  18 advantageous	  when	  rare,	  such	  that	  the	  donor	  of	  an	  infecting	  MGE	  is	  unlikely	  to	  have	  the	  19 same	  system19,	  but	  typically	  futile	  when	  ubiquitous.	  Hence	  the	  co-­‐existence	  of	  lineages	  20 likely	  involves	  competition	  between	  bacteria	  and	  MGEs	  through	  ‘kill-­‐the-­‐winner’	  dynamics,	  21 a	  form	  of	  NFDS	  in	  which	  an	  increase	  in	  a	  genotype’s	  frequency	  would	  be	  associated	  with	  a	  22 counterbalancing	  rise	  in	  the	  prevalence	  of	  MGE	  genotypes	  able	  to	  infect	  such	  cells23.	  23 	  24 Annotation	  also	  suggested	  direct	  interference	  competition	  between	  bacteria	  was	  likely	  to	  be	  25 important	  in	  maintaining	  a	  diversity	  of	  lineages24.	  Bacteriocins,	  which	  mediate	  interstrain	  26 
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killing25,	  were	  significantly	  enriched	  in	  the	  accessory	  genome	  relative	  to	  the	  core	  (Fisher’s	  1 exact	  test;	  OR	  =	  24.0;	  two-­‐sided	  p	  <	  2.2x10-­‐16).	  Although	  regulatory	  components	  of	  the	  2 bacteriocin-­‐like	  peptide	  (blp)	  locus	  were	  conserved	  across	  the	  population,	  most	  of	  the	  gene	  3 cluster	  was	  composed	  of	  various	  combinations	  of	  bacteriocin	  and	  immunity	  protein	  genes,	  4 many	  of	  which	  were	  found	  in	  multiple	  loci26.	  Despite	  this	  diversity,	  each	  of	  the	  previously-­‐5 described	  fifteen	  monophyletic	  sequence	  clusters14	  was	  typically	  associated	  with	  one	  6 distinctive	  blp	  allele	  (Supplementary	  Fig	  1),	  with	  an	  exception	  being	  sequence	  clusters	  (SCs)	  7 3	  and	  14,	  which	  did	  not	  co-­‐exist	  for	  long	  owing	  to	  vaccine-­‐induced	  population	  dynamics14.	  	  8 	  9 Sequence	  clusters	  also	  varied	  in	  their	  complement	  of	  rarer	  bacteriocin	  biosynthesis	  gene	  10 clusters,	  including	  pneumocyclicin27,	  pneumolancidin28,	  two	  loci	  likely	  regulated	  by	  the	  11 TprA/PhrA	  quorum-­‐sensing	  system29,	  and	  other	  putative	  loci	  (Supplementary	  Fig	  1).	  No	  12 individual	  gene	  cluster	  replicated	  the	  diversity	  of	  the	  blp	  locus,	  with	  sequence	  variation	  13 instead	  often	  corresponding	  to	  disruptive	  mutations	  in	  bacteriocin	  structural	  or	  14 biosynthetic	  genes.	  Assuming	  relevant	  phenotypes	  can	  be	  reliably	  inferred	  from	  the	  gene	  15 clusters,	  such	  mutations	  result	  in	  bacteria	  immune	  to	  the	  bacteriocin,	  but	  unable	  to	  kill	  16 competitors.	  These	  immune	  non-­‐producers	  co-­‐circulate	  with	  producer	  cells	  carrying	  the	  17 putatively	  fully-­‐functional	  allele,	  and	  susceptible	  cells	  completely	  lacking	  the	  gene	  cluster.	  18 Analogous	  variation	  with	  respect	  to	  individual	  bacteriocins	  is	  likely	  present	  between	  the	  blp	  19 loci,	  given	  their	  diverse	  complements	  of	  production	  and	  immunity	  genes.	  If	  both	  20 biosynthesis	  and	  immunity	  functions	  are	  costly,	  these	  phenotypes	  can	  co-­‐exist	  through	  21 rock-­‐paper-­‐scissors	  NFDS	  dynamics	  as	  producers	  kill	  susceptible	  cells,	  immune	  non-­‐22 producers	  outcompete	  producers,	  and	  susceptible	  cells	  outcompete	  immune	  non-­‐23 producers30.	  Hence	  the	  distinctive	  overall	  bacteriocin	  production	  profile	  of	  strains	  may	  be	  24 shaped	  by	  NFDS	  acting	  on	  multiple	  loci.	  25 	  26 
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NFDS	  can	  also	  result	  from	  competition	  for	  resources20,31.	  A	  particular	  nutrient	  import	  1 strategy,	  either	  optimized	  for	  different	  nutrients31	  or	  different	  concentrations	  of	  the	  same	  2 nutrient32,	  will	  become	  less	  advantageous	  as	  it	  becomes	  more	  common,	  as	  a	  consequence	  of	  3 more	  intense	  competition	  for	  the	  same	  resource24.	  While	  nutrient	  importers	  account	  for	  4 11.5%	  of	  the	  core	  COGs,	  because	  many	  are	  universally	  necessary,	  they	  also	  make	  up	  9.35%	  5 of	  the	  intermediate-­‐frequency	  COGs.	  Hence	  they	  are	  significantly	  enriched	  relative	  to	  6 general	  metabolic	  genes	  in	  the	  latter	  category	  (Fisher’s	  exact	  test,	  OR	  =	  2.48,	  two-­‐sided	  p	  =	  7 2.61x10-­‐8).	  This	  suggests	  NFDS	  may	  sustain	  multiple	  nutrient	  acquisition	  strategies	  in	  the	  8 population	  as	  a	  consequence	  of	  interstrain	  competition	  for	  resources.	  9 	  10 Antibiotic	  resistance,	  also	  variable	  between	  isolates,	  could	  be	  affected	  by	  similar	  11 competition33.	  If	  resistant	  bacteria	  are	  considered	  adapted	  to	  hosts	  consuming	  antibiotics,	  12 but	  suffering	  a	  cost	  in	  untreated	  hosts,	  then	  resistance	  will	  be	  most	  effective	  as	  a	  resource	  13 acquisition	  strategy	  where	  rare	  owing	  to	  the	  lessened	  competition	  with	  other	  strains.	  This	  14 could	  directly	  result	  in	  NFDS,	  although	  there	  are	  alternative	  explanations	  for	  the	  co-­‐15 existence	  of	  sensitive	  and	  resistant	  pneumococci	  that	  instead	  imply	  NFDS	  through	  other	  16 mechanisms34.	  17 	  18 A	  further	  functional	  category	  to	  be	  enriched	  in	  the	  intermediate-­‐frequency	  COGs	  relative	  to	  19 the	  core	  genome	  were	  genes	  encoding	  for	  the	  biosynthesis	  of	  immunogenic	  structures,	  such	  20 as	  surface	  proteins35	  or	  the	  capsule36	  (Fisher’s	  exact	  test,	  OR	  =	  2.56,	  two-­‐sided	  p	  =	  9.23x10-­‐21 
10).	  These	  can	  be	  under	  NFDS	  as	  long	  as	  alleles	  are	  immunologically	  distinguishable,	  a	  22 criterion	  met	  by	  the	  serotype-­‐defining	  capsule36,	  as	  well	  as	  accessory	  antigens	  that	  are	  23 typically	  either	  present	  as	  large	  surface	  structures,	  or	  completely	  absent,	  such	  as	  the	  pili37.	  24 	  25 
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Therefore	  multiple	  disparate	  functions	  enriched	  in	  the	  intermediate-­‐frequency	  genes	  1 relative	  to	  the	  core	  genome	  can	  each	  be	  understood	  as	  being	  subject	  to	  NFDS,	  albeit	  through	  2 different	  processes.	  While	  no	  NFDS	  mechanism	  could	  be	  identified	  for	  32.1%	  of	  the	  3 intermediate	  frequency	  COGs,	  this	  category	  is	  likely	  to	  include	  both	  metabolic	  enzymes	  and	  4 signal	  transduction	  proteins	  linked	  to	  loci	  under	  NFDS	  on	  genomic	  islands,	  and	  loci	  under	  5 NFDS	  that	  cannot	  be	  identified	  as	  such	  owing	  to	  incomplete	  functional	  information.	  	  To	  test	  6 whether	  these	  inferences	  applied	  to	  other	  pneumococcal	  populations	  in	  a	  similar	  manner,	  7 further	  genomic	  datasets	  were	  compared	  to	  those	  from	  Massachusetts.	  8 
	  9 
Population	  similarities	  in	  frequencies	  of	  genes,	  but	  not	  genotypes	  10 Overall,	  4,127	  isolates	  were	  combined	  from	  available	  reference	  sequences,	  Massachusetts,	  11 Southampton,	  Nijmegen,	  and	  the	  Maela	  refugee	  camp	  in	  Thailand	  where	  the	  population	  is	  12 unvaccinated38	  (Supplementary	  Dataset	  3).	  A	  new	  analysis	  identified	  11,049	  ‘global’	  COGs	  13 (gCOGs),	  from	  which	  a	  ‘relaxed’	  core	  of	  1,447	  gCOGs	  was	  extracted	  to	  generate	  a	  maximum	  14 likelihood	  phylogeny	  (Fig	  1b;	  Supplementary	  Fig	  2).	  Strikingly,	  there	  was	  little	  evidence	  of	  15 genetic	  isolation-­‐by-­‐distance,	  as	  both	  vaccine-­‐type	  status	  and	  country	  of	  isolation	  had	  a	  16 polyphyletic	  distribution,	  indicating	  a	  history	  of	  recombination	  and	  frequent	  international	  17 migration.	  18 	  19 The	  core	  alignment	  was	  also	  used	  to	  define	  74	  sequence	  clusters.	  Plotting	  the	  pairwise	  core	  20 genome	  divergence	  of	  isolates,	  represented	  by	  their	  cophenetic	  separation	  in	  the	  tree,	  21 against	  their	  accessory	  genome	  divergence,	  calculated	  as	  the	  Jaccard	  distance	  between	  the	  22 isolates’	  gCOG	  content,	  demonstrated	  members	  of	  the	  same	  sequence	  cluster	  were	  23 substantially	  more	  similar	  in	  their	  accessory,	  as	  well	  as	  core,	  genomes	  (Fig	  1c).	  These	  24 differences	  between	  lineages	  were	  likely	  biologically	  meaningful,	  as	  they	  represented	  a	  25 significant	  proportion	  of	  the	  accessory	  genome	  and	  were	  preserved	  despite	  international	  26 dissemination	  of	  some	  genotypes	  and	  ongoing	  horizontal	  DNA	  transfer.	  Although	  some	  of	  27 
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the	  previously-­‐identified	  atypical	  unencapsulated	  lineages	  were	  associated	  with	  extensive	  1 private	  gene	  content21,	  sequence	  clusters	  of	  encapsulated	  pneumococci	  each	  contained	  few	  2 unique	  accessory	  loci.	  The	  mean	  numbers	  of	  gCOGs	  present	  in	  ≥95%	  of	  the	  isolates	  in	  a	  3 given	  sequence	  cluster,	  but	  not	  meeting	  this	  criterion	  in	  any	  other	  sequence	  cluster	  in	  the	  4 same	  population,	  were	  just	  16.75	  in	  Massachusetts,	  19.94	  in	  Southampton,	  19.46	  in	  5 Nijmegen,	  and	  15.02	  Maela	  (Supplementary	  Fig	  2).	  Sequence	  clusters’	  distinctiveness	  6 instead	  resulted	  from	  the	  polyclonal	  distribution	  of	  the	  1,731	  intermediate	  frequency	  7 gCOGs,	  present	  in	  between	  5%	  and	  95%	  of	  the	  pre-­‐vaccination	  isolates	  in	  at	  least	  one	  8 population	  (Supplementary	  Fig	  2).	  Hence	  a	  long	  history	  of	  recombination	  was	  reflected	  in	  9 intermediate-­‐frequency	  loci	  being	  associated	  with	  multiple	  lineages,	  with	  each	  lineage	  in	  10 turn	  defined	  by	  a	  unique	  combination	  of	  intermediate-­‐frequency	  loci.	  11 	  12 Despite	  the	  lineages	  representing	  discrete	  and	  distinct	  sets	  of	  genotypes,	  their	  prevalences	  13 were	  highly	  heterogeneous	  between	  the	  four	  populations,	  with	  a	  significant	  correlation	  only	  14 between	  those	  in	  Massachusetts	  and	  Southampton	  (Fig	  2a).	  In	  marked	  contrast,	  the	  15 frequencies	  of	  accessory	  gCOGs	  were	  strongly	  correlated	  between	  Massachusetts	  and	  every	  16 other	  population	  (Fig	  2b;	  Pearson	  correlation,	  two-­‐sided	  p	  <	  10-­‐15	  in	  all	  comparisons).	  This	  17 suggests	  pneumococcal	  populations	  are	  configured	  by	  genomic	  islands	  being	  maintained	  at	  18 equilibrium	  frequencies	  that	  are	  conserved	  between	  populations,	  consistent	  with	  their	  19 prevalence	  being	  influenced	  by	  NFDS19.	  A	  significant	  deviation	  between	  populations	  was	  the	  20 elevated	  frequency	  of	  Tn916	  in	  Maela;	  this	  transposon	  underlies	  tetracycline	  resistance21,	  21 and	  therefore	  the	  difference	  is	  likely	  to	  represent	  a	  location-­‐specific	  selection	  pressure	  22 rather	  than	  drift39.	  Hence	  selection	  appears	  to	  shape	  pneumococcal	  populations	  to	  be	  23 similar	  in	  frequencies	  of	  genes,	  rather	  than	  genotypes.	  24 
	  25 
Vaccination	  as	  a	  test	  of	  negative	  frequency-­‐dependent	  selection	  26 
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The	  partial-­‐coverage	  vaccines	  introduced	  to	  limit	  pneumococcal	  disease	  can	  be	  used	  as	  a	  1 natural	  experiment,	  to	  test	  whether	  loci	  expected	  to	  change	  in	  frequency	  due	  to	  association	  2 with	  VTs	  were	  actually	  maintained	  at	  equilibrium	  frequencies	  by	  NFDS.	  Although	  a	  3 significant	  correlation	  existed	  between	  pre-­‐	  and	  post-­‐PCV7	  sequence	  cluster	  frequencies	  in	  4 the	  three	  vaccinated	  populations	  (Fig	  2c),	  divergence	  in	  population	  composition	  was	  driven	  5 by	  the	  replacement	  of	  some	  VT	  sequence	  clusters	  with	  distantly-­‐related	  NVT	  lineages.	  6 Across	  all	  comparisons	  of	  pre-­‐	  and	  post-­‐PCV7	  populations,	  gCOG	  frequencies	  showed	  a	  7 stronger	  positive	  correlation.	  This	  stability	  in	  gene	  frequencies	  reflected	  the	  significant	  8 correlation	  between	  the	  post-­‐PCV7	  decrease	  in	  a	  gCOG’s	  absolute	  frequency	  in	  VT	  isolates,	  9 and	  the	  contemporaneous	  increase	  in	  its	  absolute	  frequency	  in	  NVT	  isolates	  10 (Supplementary	  Fig	  3),	  consistent	  with	  the	  NFDS	  hypothesis.	  The	  greatest	  deviation	  in	  the	  11 Massachusetts	  population	  was	  wciN,	  directly	  involved	  in	  the	  synthesis	  of	  the	  vaccine-­‐12 targeted	  6A	  and	  6B	  capsules,	  reflecting	  differences	  in	  selection	  pressures	  between	  13 timepoints14.	  This	  suggested	  the	  equilibrium	  frequencies	  of	  the	  intermediate	  frequency	  14 gCOGs	  were	  likely	  to	  govern	  the	  post-­‐vaccine	  restructuring	  of	  the	  population.	  15 	  16 To	  quantify	  whether	  NFDS	  of	  intermediate	  frequency	  gCOGs	  could	  explain	  changes	  in	  17 pneumococcal	  populations	  better	  than	  a	  neutral	  model,	  a	  discrete	  time	  Wright-­‐Fisher	  18 multilocus	  NFDS	  model	  was	  constructed	  in	  which	  the	  number	  of	  offspring	  produced	  by	  a	  19 genotype	  i	  at	  generation	  t,	  Xi,t,	  was	  distributed	  as:	  20 	  21 
𝑋!,!~𝑃𝑜𝑖𝑠 𝜅𝑁! 1 −𝑚 1 − 𝑣! 1 + 𝜎! !!,! 	  	  22 General	  density-­‐dependent	  competition	  was	  parameterised	  by	  the	  total	  number	  of	  23 pneumococci	  in	  the	  simulated	  population	  at	  time	  t,	  Nt,	  and	  the	  environment’s	  carrying	  24 
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capacity,	  κ.	  This	  was	  constant	  across	  t,	  reflecting	  the	  stable	  levels	  of	  pneumococcal	  carriage	  1 post-­‐PCV715,16.	  The	  other	  demographic	  process	  was	  migration,	  at	  rate	  m	  (per	  month-­‐long	  2 generation),	  by	  which	  isolates	  in	  the	  resident	  simulated	  population	  were	  replaced	  by	  3 genotypes	  randomly	  selected	  from	  the	  genomic	  data	  from	  the	  same	  location.	  VT	  genotypes	  4 were	  subject	  to	  a	  fitness	  cost,	  v,	  representing	  vaccine	  efficacy	  at	  preventing	  transmission.	  5 The	  final	  term	  parameterised	  NFDS,	  the	  strength	  of	  which	  was	  determined	  by	  σf	  and	  the	  6 exponent	  πi,t:	  7 	  8 
𝜋!,! = 𝑔!,! 𝑒! − 𝑓!,!!!!! 	  	  9 where	  l	  is	  an	  intermediate	  frequency	  locus	  (gCOG	  or	  antibiotic	  resistance	  phenotype),	  and	  10 
gi,l	  is	  a	  binary	  variable	  indicating	  whether	  l	  is	  present	  in	  genotype	  i.	  Each	  l	  has	  an	  11 equilibrium	  frequency	  el,	  its	  prevalence	  in	  the	  pre-­‐vaccination	  sample,	  and	  an	  instantaneous	  12 frequency	  at	  generation	  t,	  fl,t.	  Therefore	  fl,t	  determines	  whether	  l	  benefits	  its	  host,	  when	  it	  is	  13 rare	  relative	  to	  el,	  or	  has	  a	  net	  cost,	  when	  it	  is	  common	  relative	  to	  el.	  Model	  details	  are	  14 described	  in	  Supplementary	  Fig	  4	  and	  the	  Methods.	  15 	  16 The	  σf,	  v	  and	  m	  parameters	  were	  estimated	  for	  the	  Massachusetts	  population	  using	  17 Approximate	  Bayesian	  Computation,	  an	  inference	  technique	  for	  intractable	  simulator-­‐based	  18 models40,41.	  The	  simulated	  population	  was	  compared	  to	  the	  sequence	  cluster	  distribution	  19 across	  three	  time	  points	  (Fig	  3a)	  using	  the	  Jensen-­‐Shannon	  divergence	  (JSD)	  to	  determine	  20 similarity.	  Convergence	  of	  the	  parameter	  estimates	  found	  strong	  evidence	  for	  NFDS	  (σf	  21 significantly	  greater	  than	  its	  lower	  bound;	  Table	  1	  &	  Supplementary	  Table	  1,	  22 Supplementary	  Fig	  5).	  The	  precedent	  of	  other	  models4,6	  suggested	  the	  fit	  could	  be	  improved	  23 by	  allowing	  the	  strength	  of	  selection	  to	  be	  heterogeneous	  across	  loci.	  Hence	  an	  expanded	  24 
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model	  featured	  a	  proportion,	  pf,	  of	  the	  intermediate	  frequency	  loci	  experiencing	  NFDS	  at	  1 strength	  σf,	  while	  (1-­‐pf)	  experienced	  NFDS	  at	  strength	  σw	  (see	  Methods).	  Convergence	  of	  2 parameter	  estimates	  again	  found	  strong	  evidence	  for	  NFDS	  (σf	  and	  pf	  significantly	  greater	  3 than	  their	  lower	  bounds;	  Table	  1	  &	  Supplementary	  Table	  1,	  Supplementary	  Fig	  5),	  with	  a	  4 substantial	  improvement	  over	  the	  homogeneous	  selection	  model,	  as	  quantified	  by	  the	  5 significantly	  smaller	  JSD	  values	  from	  appropriately	  parameterised	  simulations	  (Wilcoxon	  6 test	  on	  100	  simulation	  pairs,	  W	  =	  9902,	  two-­‐sided	  p	  =	  4.73x10-­‐33;	  Supplementary	  Fig	  6).	  7 	  8 At	  the	  locus	  level,	  those	  genes	  subject	  to	  stronger	  NFDS	  stabilised	  close	  to	  their	  equilibrium	  9 frequencies,	  whereas	  the	  frequencies	  of	  those	  subject	  to	  weaker	  NFDS	  drifted	  near-­‐10 neutrally	  (Supplementary	  Fig	  6).	  At	  the	  lineage	  level,	  these	  simulations	  replicated	  three	  11 important	  facets	  of	  the	  post-­‐vaccination	  population	  dynamics	  (Fig	  3a	  &	  Supplementary	  Fig	  12 7).	  The	  first	  was	  the	  stable	  post-­‐vaccine	  prevalence	  of	  some	  NVT	  sequence	  clusters,	  such	  as	  13 SC4	  and	  SC8.	  The	  second	  was	  serotype	  switching,	  the	  replacement	  of	  VT	  by	  NVT	  within	  14 sequence	  clusters	  that	  remained	  at	  stable	  overall	  frequencies,	  as	  observed	  in	  SC1,	  SC5,	  SC9	  15 and	  SC15.	  The	  third	  was	  clonal	  replacement	  of	  VT	  by	  unrelated	  NVT,	  such	  as	  the	  16 contemporaneous	  disappearance	  of	  SC13,	  SC14,	  SC22	  and	  SC24,	  and	  expansion	  of	  SC3,	  SC6,	  17 SC7	  and	  SC11.	  These	  trends	  were	  not	  trivial	  to	  replicate.	  The	  same	  framework	  was	  used	  to	  18 fit	  a	  neutral	  model	  (NFDS	  eliminated,	  with	  σf	  =	  0);	  a	  serotype-­‐focused	  single	  locus	  NFDS	  19 model	  (el	  applied	  to	  serotype,	  rather	  than	  locus,	  frequencies),	  and	  an	  ecotype	  model	  (el	  20 applied	  to	  sequence	  cluster,	  rather	  than	  locus,	  frequencies).	  Both	  the	  neutral	  and	  serotype	  21 models	  poorly	  reproduced	  the	  stability	  of	  SC8’s	  frequency,	  serotype	  switching	  within	  SC9	  22 and	  SC15,	  or	  any	  patterns	  of	  clonal	  expansion.	  The	  ecotype	  models	  better	  reproduced	  NVT	  23 sequence	  cluster	  stability	  and	  serotype	  switching,	  but	  did	  not	  replicate	  the	  observed	  24 patterns	  of	  clonal	  replacement.	  All	  of	  these	  models	  resulted	  in	  significantly	  worse	  fits	  to	  the	  25 data	  than	  the	  heterogeneous	  multilocus	  NFDS	  model	  (Supplementary	  Figs	  6	  &	  7).	  26 
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  1 The	  estimated	  vaccine	  selection	  strength,	  v,	  of	  0.081	  per	  month	  from	  the	  heterogenous	  rate	  2 multilocus	  NFDS	  is	  consistent	  with	  PCV7’s	  halving	  of	  the	  rate	  at	  which	  VT	  are	  acquired42,	  if	  3 pneumococci	  transmit	  at	  least	  once	  every	  six	  months,	  an	  interval	  similar	  to	  the	  carriage	  4 duration	  of	  VT	  serotypes43.	  Similarly,	  the	  estimated	  migration	  rate,	  m,	  of	  0.0044	  per	  month	  5 suggests	  half	  the	  resident	  Massachusetts	  pneumococcal	  population	  is	  replaced	  by	  6 immigrant	  strains	  over	  approximately	  13	  years,	  which	  is	  realistic	  given	  the	  50%	  probability	  7 that	  a	  pneumococcal	  lineage	  was	  detectable	  in	  different	  localities	  within	  Massachusetts	  8 after	  3-­‐4	  years14.	  9 
	  10 
Consistent	  evidence	  of	  NFDS	  in	  other	  populations	  11 The	  homogeneous	  and	  heterogeneous	  multilocus	  NFDS	  models	  were	  also	  fitted	  to	  similar	  12 surveillance	  data	  from	  Southampton	  (Supplementary	  Fig	  5	  &	  8).	  The	  JSD	  values	  for	  the	  13 heterogenous	  rate	  model	  were	  again	  reproducible	  and	  significantly	  smaller	  than	  for	  the	  14 homogeneous	  rate	  version	  (Wilcoxon	  test	  on	  100	  simulation	  pairs,	  W	  =	  9954,	  two-­‐sided	  p	  =	  15 1.01x10-­‐33).	  The	  point	  estimates	  of	  parameter	  values	  were	  again	  robust	  and,	  in	  the	  case	  of	  16 the	  three	  parameters	  determining	  the	  strength	  of	  NFDS,	  very	  similar	  to	  those	  for	  17 Massachusetts	  (Table	  1	  &	  Supplementary	  Table	  1).	  	  18 	  19 However,	  the	  vaccine	  selection	  strength	  was	  estimated	  to	  be	  2.54-­‐fold	  higher	  in	  20 Southampton	  than	  in	  Massachusetts.	  This	  difference	  is	  likely	  attributable	  to	  the	  21 substantially	  higher	  PCV7	  coverage	  in	  children	  under	  24	  months	  of	  age	  in	  the	  years	  22 immediately	  after	  the	  vaccine’s	  introduction	  in	  the	  UK	  relative	  to	  the	  USA44,45,	  combined	  23 with	  the	  lower	  age	  range	  included	  in	  the	  Southampton	  study,	  excluding	  older	  children	  who	  24 are	  less	  likely	  to	  have	  been	  immunized,	  or	  in	  whom	  natural	  acquisition	  of	  immunity	  blunted	  25 the	  selective	  pressure	  of	  the	  vaccine16,46.	  Simulations	  using	  these	  point	  estimates	  again	  26 
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replicated	  the	  strain	  dynamics	  observed	  in	  the	  genomic	  sample	  (Fig	  3b).	  VT	  SC5	  and	  SC18	  1 were	  eliminated	  at	  realistic	  rates;	  NVT	  SC3,	  SC19	  and	  SC35	  remained	  at	  stable	  frequencies;	  2 serotype	  switching	  occurred	  within	  SC1	  and	  SC9,	  while	  NVT	  SC2	  rose	  in	  prevalence	  at	  a	  3 much	  faster	  rate	  than	  same	  lineage	  did	  in	  Massachusetts.	  4 	  5 The	  homogeneous	  and	  heterogeneous	  rate	  multilocus	  NFDS	  models	  were	  also	  fitted	  to	  a	  6 genomic	  dataset	  from	  cases	  of	  invasive	  pneumococcal	  disease	  in	  Nijmegen.	  The	  7 heterogeneous	  model	  was	  again	  a	  significantly	  closer	  fit	  to	  the	  genomic	  data,	  as	  assessed	  by	  8 the	  JSDs	  (Wilcoxon	  test,	  W	  =	  3988,	  two-­‐sided	  p	  =	  0.0135;	  Table	  1	  and	  Supplementary	  Fig	  5).	  9 Precisely	  replicating	  the	  observed	  population	  dynamics	  was	  difficult	  (Fig	  3c	  and	  10 Supplementary	  Fig	  9),	  owing	  to	  the	  sparser	  sampling,	  particularly	  post-­‐PCV7,	  and	  inevitable	  11 bias	  towards	  more	  invasive	  genotypes	  in	  this	  dataset.	  While	  the	  estimated	  strength	  of	  NFDS	  12 was	  similar	  to	  both	  Massachusetts	  and	  Southampton,	  the	  estimated	  vaccine	  selection	  13 strength	  was	  lower	  than	  in	  these	  infant	  carriage	  surveillance	  projects,	  consistent	  with	  the	  14 Nijmegen	  collection	  being	  isolated	  in	  an	  adult	  population	  primarily	  protected	  by	  herd	  15 immunity18.	  Correspondingly,	  fitting	  the	  heterogenous	  rate	  model	  to	  the	  Maela	  dataset,	  16 isolated	  from	  an	  entirely	  unvaccinated	  community,	  estimated	  v	  close	  to	  zero	  (Table	  1).	  17 	  18 NFDS	  acting	  on	  genomic	  islands	  can	  also	  affect	  variation	  in	  the	  core	  genome.	  Comparisons	  19 between	  pre-­‐	  and	  post-­‐vaccination	  populations,	  and	  between	  different	  locations,	  revealed	  20 allele	  frequencies	  of	  core	  genome	  single	  nucleotide	  polymorphisms	  (SNPs)	  typically	  showed	  21 very	  similar	  correlations	  to	  those	  of	  accessory	  loci	  frequencies	  (Supplementary	  Fig	  10).	  This	  22 was	  not	  a	  consequence	  of	  tight	  linkage	  between	  SNPs	  in	  the	  regions	  flanking	  genomic	  23 islands	  (Supplementary	  Fig	  10).	  Nevertheless,	  simulations	  in	  which	  NFDS	  acted	  on	  only	  24 accessory	  loci	  precisely	  replicated	  the	  post-­‐vaccination	  changes	  in	  the	  core	  SNP	  allele	  25 frequencies,	  and	  similar	  correlations	  to	  those	  between	  collections	  were	  observed	  in	  26 
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simulations	  where	  the	  Massachusetts	  population	  was	  gradually	  replaced	  with	  isolates	  from	  1 other	  datasets	  (Supplementary	  Fig	  10).	  Therefore	  while	  it	  is	  possible	  core	  genome	  loci	  may	  2 also	  be	  under	  NFDS,	  the	  observed	  correlations	  can	  be	  attributed	  to	  NFDS	  acting	  only	  on	  3 accessory	  loci.	  4 	  5 
Consequences	  of	  NFDS	  for	  the	  impact	  of	  vaccination	  6 Simulations	  were	  used	  to	  investigate	  counterfactual	  scenarios.	  In	  the	  absence	  of	  vaccination	  7 (v	  =	  0),	  the	  pre-­‐PCV7	  populations	  were	  stable	  in	  Massachusetts	  (Supplementary	  Fig	  7),	  8 Southampton	  (Supplementary	  Fig	  8)	  and	  Nijmegen	  (Supplementary	  Fig	  9).	  Eliminating	  9 migration	  (m	  =	  0)	  significantly	  increased	  the	  proportion	  of	  VTs	  observed	  in	  simulations	  in	  10 all	  three	  populations	  (Wilcoxon	  tests;	  Massachusetts,	  W	  =	  0,	  two-­‐sided	  p	  =	  2.56x10-­‐34;	  11 Southampton,	  W	  =	  0,	  two-­‐sided	  p	  =	  2.56x10-­‐34;	  Nijmegen,	  W	  =	  1453,	  two-­‐sided	  p	  =	  4.50x10-­‐12 
18),	  highlighting	  the	  importance	  of	  imported	  or	  previously	  rare	  NVTs	  in	  driving	  out	  VTs.	  13 However,	  removing	  NFDS	  significantly	  decreased	  the	  proportion	  of	  VTs	  observed	  in	  all	  14 three	  populations	  (Wilcoxon	  tests;	  W	  =	  10000,	  two-­‐sided	  p	  =	  2.56x10-­‐34	  in	  Massachusetts	  15 and	  Southampton;	  W	  =	  9979,	  two	  sided	  p	  =	  4.81x10-­‐34	  in	  Nijmegen).	  This	  is	  because	  16 following	  vaccination,	  those	  loci	  enriched	  in	  VT	  genotypes	  become	  increasingly	  17 advantageous	  to	  their	  bacterial	  hosts	  as	  they	  become	  rarer,	  resulting	  in	  NFDS	  slowing	  the	  18 rate	  at	  which	  VT	  genotypes	  are	  eliminated	  until	  such	  loci	  rise	  in	  frequency	  in	  NVT	  19 genotypes.	  20 	  21 
Discussion	  22 These	  combined	  analyses	  of	  multiple	  population	  genomic	  datasets	  suggest	  that	  NFDS	  plays	  23 an	  important	  role	  both	  in	  the	  stable	  structuring	  of	  pneumococcal	  populations,	  and	  their	  24 dynamics	  following	  disruption	  by	  vaccine-­‐induced	  immunity.	  According	  to	  the	  best-­‐fitting	  25 model,	  relatively	  strong	  NFDS	  acts	  on	  a	  few	  hundred	  accessory	  genes,	  corresponding	  to	  26 
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5.0%	  of	  the	  Massachusetts	  pangenome,	  and	  8.3%	  of	  that	  in	  Southampton.	  This	  cumulative	  1 effect	  across	  multiple	  loci	  in	  complex	  populations	  is	  predicted	  to	  maintain	  stable	  lineage	  2 compositions	  in	  the	  absence	  of	  disruption	  by	  vaccination,	  without	  the	  oscillatory	  dynamics	  3 associated	  with	  some	  single	  locus	  NFDS	  processes19,30,47,48.	  Hence	  multiple	  lineages	  can	  4 persistently	  coexist	  within	  this	  framework	  despite	  their	  confinement	  to	  a	  niche,	  the	  human	  5 nasopharynx,	  that	  is	  physiochemically	  homogeneous	  compared	  with	  the	  varied	  6 environments	  inhabited	  by	  species	  often	  considered	  as	  split	  into	  ecotypes,	  such	  as	  7 
Escherichia	  coli.	  Furthermore,	  although	  intraspecific	  recombinations	  are	  slow	  over	  the	  8 timescales	  simulated	  in	  this	  study14,	  horizontal	  DNA	  transfer	  has	  comprehensively	  9 reassorted	  genomic	  islands	  between	  genotypes	  over	  the	  species’	  history.	  Their	  consequent	  10 polyclonal	  distribution	  means	  accessory	  locus	  frequencies	  can	  be	  preserved	  by	  multiple	  11 lineage	  combinations,	  thereby	  accounting	  for	  the	  diverse	  population	  structures	  observed	  12 globally,	  and	  the	  panoply	  of	  strains	  they	  contain49.	  While	  the	  NFDS	  processes	  represented	  in	  13 the	  multilocus	  model	  were	  also	  sufficient	  to	  explain	  the	  major	  post-­‐vaccination	  population	  14 changes,	  further	  work	  is	  required	  to	  determine	  whether	  core	  loci	  are	  also	  involved.	  15 Continued	  development	  of	  such	  quantitative	  models	  with	  large	  genomic	  datasets	  promises	  16 to	  improve	  our	  understanding	  of	  how	  diverse	  selective	  pressures	  affecting	  bacterial	  17 populations	  shape	  their	  response	  to	  public	  health	  interventions,	  and	  how	  best	  to	  design	  18 novel	  pathogen	  control	  strategies.	  	  19 	  20 
Methods	  21 
Annotation	  of	  the	  accessory	  genome	  22 The	  previously	  analysed	  Massachusetts	  population14,50	  contained	  1,112	  COGs	  present	  in	  23 between	  5%	  and	  95%	  of	  the	  616	  isolates	  and	  1,194	  COGs	  present	  in	  a	  single	  copy	  in	  every	  24 isolate.	  Information	  on	  whether	  these	  were	  associated	  with	  capsule	  polysaccharide	  25 synthesis,	  antibiotic	  resistance,	  RMSs,	  Pneumococcal	  Pathogenicity	  Island	  1	  or	  MGEs	  was	  26 
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extracted	  from	  previously	  described	  analyses14,21,50.	  Coding	  sequences	  (CDSs)	  associated	  1 with	  proteinaceous	  immunogenic	  structures	  were	  identified	  through	  the	  results	  of	  protein	  2 antigen	  array	  data35.	  Candidate	  bacteriocins	  were	  identified	  using	  the	  BAGEL3	  algorithm51.	  3 The	  variation	  at	  the	  blp	  locus,	  and	  the	  other	  putative	  bacteriocin	  production	  loci,	  was	  4 manually	  identified	  within	  de	  novo	  assemblies	  of	  the	  Massachusetts	  isolates	  using	  Artemis	  5 and	  ACT52.	  The	  heatmap	  showing	  the	  distribution	  of	  the	  blp	  alleles	  in	  Supplementary	  Fig	  1	  6 was	  generated	  by	  mapping	  Illumina	  reads	  for	  each	  of	  the	  Massachusetts	  isolates	  against	  the	  7 concatenated	  set	  of	  loci	  using	  BWA	  with	  default	  settings53.	  Further	  information	  on	  COG	  8 functional	  domains14	  and	  previous	  automated	  annotations50	  was	  additionally	  used	  to	  9 manually	  curate	  all	  available	  information	  into	  the	  annotation	  and	  classification	  in	  10 Supplementary	  Datasets	  1	  and	  2.	  11 	  12 
Bioinformatic	  analysis	  of	  genomic	  data	  13 The	  isolate	  collections	  analysed	  each	  came	  from	  systematic	  sampling	  of	  defined	  host	  14 populations.	  The	  Massachusetts	  pneumococcal	  dataset,	  isolated	  from	  the	  nasopharynxes	  of	  15 children	  up	  to	  five	  years	  of	  age	  during	  routine	  primary	  care	  physician	  visits,	  consisted	  of	  the	  16 616	  de	  novo	  assemblies	  generated	  with	  Velvet54	  as	  described	  previously14,50.	  17 VelvetOptimiser55	  was	  used	  to	  assemble	  data	  from	  the	  Maela	  collection38	  (3,085	  genomes),	  18 isolated	  from	  the	  nasopharynxes	  of	  infants	  up	  to	  two	  years	  of	  age,	  and	  their	  mothers,	  in	  a	  19 Thai	  refugee	  camp;	  the	  Southampton	  collection16	  (516	  genomes),	  isolated	  from	  the	  20 nasopharynxes	  of	  children	  up	  to	  four	  years	  of	  age	  during	  outpatient	  visits;	  and	  the	  21 Nijmegen18	  collection	  (337	  genomes),	  isolated	  from	  adults	  hospitalised	  with	  bacteraemic	  22 pneumonia.	  These	  were	  supplemented	  with	  20	  complete,	  publically	  available	  reference	  23 genomes	  (Supplementary	  Dataset	  3).	  To	  standardise	  these	  genome	  collections	  relative	  to	  24 the	  Massachusetts	  dataset,	  assemblies	  were	  discarded	  if	  they	  were	  less	  than	  1.98	  Mb,	  or	  25 greater	  than	  2.19	  Mb,	  in	  length;	  or	  had	  an	  N50	  less	  than	  15	  kb14,50;	  or	  necessary	  information	  26 
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was	  absent	  from	  the	  public	  databases.	  Of	  the	  4,586	  genomes,	  4,462	  met	  these	  criteria	  and	  1 were	  included	  in	  a	  preliminary	  analysis	  that	  identified	  non-­‐pneumococcal	  streptococci,	  2 which	  were	  then	  excluded	  from	  the	  final	  analysis.	  Consequently,	  the	  final	  dataset	  of	  4,127	  3 genomes	  contained	  20	  reference	  sequences,	  616	  Massachusetts	  sequences,	  491	  4 Southampton	  sequences,	  337	  Nijmegen	  sequences,	  and	  2,663	  Maela	  sequences.	  5 	  6 Each	  genome	  was	  processed	  with	  RNAmmer	  v1.2,	  to	  annotate	  rRNA56;	  tRNAscan-­‐SE	  v1.3.1,	  7 to	  annotate	  tRNA57;	  Rfam	  scan,	  to	  annotate	  other	  non-­‐coding	  RNA58;	  scanned	  for	  BOX,	  RUP	  8 and	  SPRITE	  repeats	  using	  HMM	  profiles59,60;	  and	  Prodigal	  v2.661	  ,	  to	  annotate	  CDSs	  using	  a	  9 model	  trained	  on	  the	  genome	  of	  S.	  pneumoniae	  ATCC	  70066962.	  CDSs	  that	  overlapped	  with	  10 the	  non-­‐coding	  RNA	  or	  short	  interspersed	  repeat	  sequences	  were	  then	  removed	  from	  the	  11 annotation,	  and	  the	  remaining	  set	  translated	  to	  allow	  a	  non-­‐redundant	  set	  of	  proteins	  to	  be	  12 identified.	  A	  version	  without	  low	  complexity	  regions	  was	  generated	  by	  filtering	  with	  13 segmasker63	  and	  masking	  choline	  binding	  domains.	  All-­‐against-­‐all	  comparisons	  of	  these	  14 protein	  databases	  were	  then	  generated	  using	  BLAT	  v0.3464.	  Global	  COGs	  (gCOGs)	  were	  then	  15 generated	  using	  COGtriangles	  and	  COGcognitor65,	  and	  through	  linking	  pairs	  of	  highly	  similar	  16 sequences,	  as	  described	  previously14.	  The	  gCOG	  nomenclature	  was	  then	  applied	  to	  the	  full,	  17 redundant	  set	  of	  protein	  sequences.	  18 	  19 To	  correct	  for	  misassemblies,	  particularly	  those	  reflecting	  differences	  between	  the	  methods	  20 used	  to	  assemble	  the	  Massachusetts	  isolates’	  genomes	  and	  those	  from	  other	  populations,	  21 false	  positive	  CDSs	  were	  eliminated	  from	  the	  intermediate	  frequency	  gCOGs.	  A	  database	  22 generated	  from	  the	  annotation	  of	  S.	  pneumoniae	  ATCC	  70066962	  was	  used	  to	  search	  23 intermediate	  frequency	  gCOG	  DNA	  sequences	  using	  BLASTALL	  v2.2.25.	  This	  identified	  39	  24 gCOGs	  corresponding	  to	  fragments	  of	  tRNA,	  oligomers	  of	  choline	  binding	  domains,	  or	  25 antisense	  fragments	  of	  insertion	  sequences.	  This	  left	  a	  final	  set	  of	  11,049	  gCOGs,	  of	  which	  26 
 - 18 - 
1,731	  were	  present	  at	  a	  frequency	  between	  5%	  and	  95%	  in	  the	  pre-­‐	  or	  peri-­‐vaccination	  1 samples	  (grouped	  as	  “pre-­‐vaccination”	  samples	  in	  the	  Results	  section)	  of	  at	  least	  one	  of	  the	  2 four	  study	  populations.	  3 	  4 To	  transfer	  the	  functional	  annotation	  onto	  the	  gCOG	  sequences,	  the	  annotated	  protein	  5 sequences	  from	  Massachusetts	  in	  Supplementary	  Table	  1	  were	  used	  to	  identify	  identical	  6 proteins	  in	  the	  gCOG	  dataset.	  When	  COGs	  could	  not	  be	  matched	  to	  gCOGs	  through	  this	  7 approach,	  links	  were	  instead	  made	  through	  searching	  gCOGs	  for	  proteins	  with	  identity	  to	  8 the	  middle	  50%	  of	  annotated	  protein	  sequences	  from	  Massachusetts.	  These	  links	  were	  then	  9 manually	  curated	  to	  categorise	  the	  1,731	  intermediate	  frequency	  gCOG	  sequences	  where	  10 possible,	  as	  shown	  in	  Fig	  2.	  	  11 	  12 
Analysis	  of	  population	  structure	  13 To	  analyse	  the	  overall	  population	  structure,	  a	  ‘relaxed’	  core	  set	  of	  1,447	  gCOGs	  were	  14 identified	  that	  met	  two	  criteria:	  first,	  that	  they	  were	  present	  in	  at	  least	  95%	  of	  the	  isolates;	  15 and	  second,	  that	  the	  total	  number	  of	  gCOG	  representatives	  was	  less	  than	  105%	  of	  the	  16 number	  of	  isolates	  containing	  the	  gCOG,	  to	  exclude	  gCOGs	  that	  are	  present	  in	  high	  copy	  17 number	  in	  some,	  or	  all,	  genomes.	  A	  codon	  alignment	  was	  then	  generated	  for	  each	  gCOG	  18 using	  mafft	  v7.22166,	  excluding	  any	  sequences	  from	  isolates	  containing	  more	  than	  one	  19 representative	  of	  the	  gCOG.	  These	  were	  concatenated,	  with	  gap	  sites	  used	  to	  pad	  regions	  20 where	  data	  were	  missing	  for	  a	  particular	  isolate,	  and	  a	  293,508	  bp	  alignment	  of	  21 polymorphic	  sites	  extracted	  using	  SNP-­‐sites67.	  A	  phylogeny	  was	  generated	  from	  this	  22 alignment	  using	  FastTree2	  with	  the	  ‘fastest’	  option68.	  23 	  24 Population	  structure	  was	  analysed	  with	  hierarchical	  BAPS	  clustering69	  using	  five	  25 independent	  runs	  of	  the	  estimation	  algorithm	  starting	  from	  the	  upper	  bound	  of	  200-­‐500	  26 
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clusters,	  which	  all	  converged	  to	  the	  same	  posterior	  mode.	  Two	  polyphyletic	  primary	  BAPS	  1 clusters	  were	  split	  into	  their	  secondary	  level	  clusters,	  yielding	  73	  sequence	  clusters	  that	  2 were	  almost	  entirely	  congruent	  with	  the	  phylogeny,	  and	  SC0,	  which	  remained	  polyphyletic.	  3 The	  monophyletic	  sequence	  clusters	  most	  similar	  to	  those	  in	  Massachusetts14	  were	  4 numbered	  accordingly.	  The	  plot	  in	  Fig	  1c	  combined	  cophenetic	  distances	  from	  the	  core	  5 genome	  phylogeny,	  extracted	  with	  Bioperl70,	  and	  Jaccard	  distance	  calculated	  from	  the	  6 presence	  and	  absence	  matrix	  of	  gCOGs	  using	  the	  R	  package	  vegan71.	  For	  each	  isolate,	  100	  7 comparator	  isolates	  were	  selected	  at	  random,	  and	  this	  sample	  of	  pairwise	  comparisons	  8 used	  to	  generate	  the	  plot.	  9 	  10 Of	  the	  polymorphic	  sites	  in	  the	  core	  genome,	  282,043	  corresponded	  to	  a	  base	  in	  the	  S.	  11 
pneumoniae	  ATCC	  700669	  reference	  genome.	  For	  each	  population,	  the	  set	  of	  sites	  that	  were	  12 both	  biallelic	  and	  had	  a	  non-­‐reference	  allele	  frequency	  between	  5%	  and	  95%	  in	  that	  13 population	  were	  extracted	  with	  VCFtools	  v0.1.1472;	  there	  were	  27,616	  of	  these	  in	  the	  14 Massachusetts	  dataset,	  26,954	  in	  the	  Southampton	  dataset,	  28,396	  in	  the	  Nijmegen	  dataset,	  15 and	  30,579	  in	  the	  Maela	  dataset.	  The	  r2	  statistics	  between	  these	  polymorphic	  sites,	  and	  16 between	  the	  binary	  presence	  and	  absence	  information	  of	  accessory	  gCOGs	  with	  a	  17 representative	  in	  the	  S.	  pneumoniae	  ATCC	  700669	  genome,	  were	  then	  calculated	  with	  18 VCFtools	  by	  treating	  each	  isolate	  as	  a	  phased	  haplotype.	  These	  were	  used	  to	  generate	  the	  19 linkage	  analysis	  plots	  in	  Supplementary	  Fig	  10.	  20 	  21 
Inference	  of	  antibiotic	  resistance	  profiles	  22 Individual	  isolates’	  genotypes	  were	  used	  to	  predict	  their	  antimicrobial	  resistance	  profiles.	  23 The	  presence	  of	  aph3’	  (the	  gCOG	  CLS350021)	  was	  inferred	  to	  cause	  resistance	  to	  24 aminoglycosides;	  the	  presence	  of	  tetM	  (CLS03712)	  was	  inferred	  to	  cause	  resistance	  to	  25 tetracycline;	  the	  presence	  of	  cat	  (CLS01043)	  was	  inferred	  to	  cause	  resistance	  to	  26 
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chloramphenicol;	  and	  the	  presence	  of	  ermB	  (CLS01283),	  mef	  (CLS02227),	  or	  both	  was	  1 inferred	  to	  cause	  macrolide	  resistance62,73.	  These	  gCOGs	  themselves	  were	  removed	  from	  the	  2 set	  of	  loci	  used	  in	  the	  simulations,	  and	  the	  inferred	  antibiotic	  resistance	  phenotype	  used	  3 instead.	  4 	  5 Non-­‐susceptibility	  to	  other	  antibiotics	  is	  determined	  by	  core	  genome	  loci;	  to	  incorporate	  6 these	  into	  the	  model,	  resistant	  alleles	  of	  relevant	  loci	  were	  treated	  analogously	  to	  the	  7 presence	  of	  an	  accessory	  resistance	  gene.	  The	  presence	  of	  the	  I100L	  substitution	  in	  the	  8 dihydrofolate	  reductase	  protein	  (CLS03211)	  was	  inferred	  to	  result	  in	  resistance	  to	  9 trimethoprim74,75,	  and	  the	  presence	  of	  an	  insertion	  shortly	  after	  S61	  in	  the	  dihydropteroate	  10 synthase	  protein	  (CLS01442)	  was	  inferred	  to	  result	  in	  resistance	  to	  sulphamethoxazole76.	  11 Three	  penicillin-­‐binding	  proteins	  substantially	  contribute	  to	  β-­‐lactam	  resistance.	  Using	  a	  12 similar	  approach	  to	  that	  of	  Li	  et	  al77,	  the	  population-­‐wide	  protein	  sequences	  of	  Pbp1A	  13 (CLS01776),	  Pbp2X	  (CLS01031)	  and	  Pbp2B	  (CLS01093)	  were	  aligned	  with	  mafft	  v7.22166,	  14 and	  the	  transpeptidase	  domain	  regions	  extracted.	  Following	  validation	  using	  the	  isolates	  15 from	  Massachusetts14,	  sequences	  exhibiting	  less	  than	  97%	  amino	  acid	  identity	  with	  the	  16 susceptible	  alleles	  defined	  by	  Li	  et	  al	  in	  the	  multiple	  sequence	  alignment	  were	  considered	  17 resistance-­‐associated.	  These	  antibiotic	  resistance	  phenotypes	  were	  included	  as	  18 intermediate	  frequency	  loci	  if	  they	  met	  the	  criteria	  for	  a	  given	  population.	  19 	  20 
Multilocus	  negative	  frequency	  dependent	  selection	  model	  21 The	  multilocus	  negative	  frequency	  dependent	  selection	  model	  was	  generated	  within	  a	  22 discrete-­‐time	  Wright-­‐Fisher	  framework78,79.	  Although	  such	  models	  were	  designed	  with	  a	  23 number	  of	  strong	  assumptions,	  the	  results	  of	  simulations	  have	  been	  found	  robust	  to	  24 violations	  of	  these	  conditions80.	  Each	  individual	  i	  had	  a	  genotype	  gi	  defined	  by	  a	  binary	  25 string	  representing	  the	  presence	  and	  absence	  of	  each	  gCOG	  or	  antibiotic	  resistance	  26 
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phenotype	  present	  at	  an	  intermediate	  frequency	  in	  the	  starting	  population.	  The	  number	  of	  1 offspring	  arising	  from	  i	  at	  time	  t	  is	  a	  Poisson-­‐distributed	  random	  variable	  Xi,t.	  This	  Poisson	  2 approximation	  is	  justifiable	  if	  only	  a	  small	  proportion	  of	  descendants	  survive	  to	  the	  next	  3 generation78,	  as	  is	  likely	  to	  be	  the	  case	  for	  a	  nasopharyngeal	  coloniser	  with	  a	  small	  within-­‐4 host	  effective	  population	  size81	  that	  experiences	  a	  strong	  bottleneck	  at	  transmission.	  To	  5 allow	  for	  differential	  reproductive	  success	  between	  genotypes	  in	  a	  manner	  that	  depended	  6 on	  the	  composition	  of	  the	  overall	  population,	  Xi,t	  was	  parameterised	  using	  the	  function	  7 (Supplementary	  Fig	  4):	  8 	  9 
𝑋!,!~𝑃𝑜𝑖𝑠 𝜅𝑁! 1 −𝑚 1 − 𝑣! 1 + 𝜎! !!,! 	  	  10 The	  four	  components	  of	  the	  function	  each	  correspond	  to	  a	  different	  biological	  process.	  11 General	  density-­‐dependent	  selection	  depends	  on	  κ,	  the	  carrying	  capacity	  of	  the	  12 environment,	  and	  Nt,	  the	  total	  number	  of	  individuals	  at	  time	  t.	  This	  maintained	  an	  13 approximately	  stable	  population	  size	  throughout	  simulations.	  This	  is	  justifiable,	  as	  S.	  14 
pneumoniae	  colonization	  levels	  did	  not	  substantially	  change	  in	  the	  years	  immediately	  after	  15 PCV7’s	  introduction.	  16 	  17 Migration	  into	  the	  population	  occurred	  at	  rate	  m,	  subject	  to	  the	  limits	  0	  ≤	  m	  ≤	  1,	  and	  18 therefore	  the	  reproductive	  fitness	  of	  resident	  individuals	  was	  reduced	  by	  a	  factor	  of	  (1-­‐m)	  19 accordingly	  to	  maintain	  an	  approximately	  constant	  population	  size	  of	  κ.	  The	  number	  of	  20 immigrating	  individuals	  at	  time	  t,	  Nm,t,	  was	  a	  random	  variable	  calculated	  as:	  21 	  22 𝑁!,!~𝐵𝑖𝑛(𝑚, 𝜅)	  	  23 
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Migrant	  individuals	  were	  selected,	  with	  replacement,	  from	  all	  isolates	  observed	  at	  any	  time	  1 point	  in	  the	  geographically-­‐specified	  dataset	  being	  studied.	  Therefore	  it	  was	  the	  only	  2 mechanism	  by	  which	  genotypes	  not	  present	  in	  the	  pre-­‐vaccine	  genome	  samples	  could	  enter	  3 the	  simulated	  population.	  To	  prevent	  artefactually	  improving	  the	  fit	  of	  the	  model	  at	  high	  4 values	  of	  m	  through	  sampling	  all	  isolates	  in	  proportion	  to	  their	  observed	  frequency,	  the	  5 selection	  of	  an	  immigrating	  isolate	  was	  biased	  such	  that	  it	  was	  equally	  likely	  to	  come	  from	  6 any	  sequence	  cluster	  with	  at	  least	  one	  representative	  in	  the	  studied	  population,	  although	  7 these	  were	  present	  at	  very	  different	  frequencies	  within	  each	  population.	  Hence	  the	  8 probability	  of	  an	  immigrating	  individual	  being	  of	  genotype	  i	  and	  sequence	  cluster	  s,	  pm,s,i,	  9 was:	  	  10 	  11 
𝑝!,!,! = 𝑛!,!𝑆𝑛!	  	  12 Where	  S	  is	  the	  number	  of	  sequence	  clusters	  in	  the	  population,	  ns,i	  is	  the	  number	  of	  isolates	  13 in	  sequence	  cluster	  s	  of	  genotype	  i	  in	  the	  genome	  dataset,	  and	  ns	  was	  the	  number	  of	  isolates	  14 in	  the	  sequence	  cluster	  s	  in	  the	  genomic	  dataset.	  15 	  16 The	  vaccine	  selection	  pressure	  to	  which	  individual	  i	  was	  subject,	  vi,	  depended	  on	  whether	  17 the	  individuals	  were	  of	  a	  vaccine	  serotype	  or	  not;	  for	  PCV7,	  the	  vaccine	  serotypes	  were	  4,	  18 6B,	  9V,	  14,	  18C,	  19F	  and	  23F,	  as	  well	  as	  6A,	  a	  vaccine-­‐related	  type	  to	  which	  PCV7	  elicited	  19 strong	  cross-­‐immunity14.	  Consequently,	  vi	  was	  determined	  as:	  20 	  21 
𝑣! 𝑣 𝑖𝑓  𝑖𝑠𝑜𝑙𝑎𝑡𝑒  ℎ𝑎𝑠  𝑎  𝑣𝑎𝑐𝑐𝑖𝑛𝑒  𝑠𝑒𝑟𝑜𝑡𝑦𝑝𝑒0 𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒 	  	  22 Where	  v	  was	  subject	  to	  the	  constraint	  0	  ≤	  v	  ≤	  1.	  23 
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  1 In	  the	  homogeneous	  rate	  multilocus	  model	  of	  NFDS,	  the	  magnitude	  of	  this	  pressure	  was	  2 determined	  by	  the	  term	   1 + 𝜎! !!,! ,	  where	  σf	  ≥	  0.	  The	  selection	  pressure	  depended	  on	  the	  3 genotype	  gi	  and	  distribution	  of	  intermediate	  frequency	  loci	  at	  time	  t,	  as	  summarised	  by	  the	  4 exponent	  πi,t.	  The	  calculation	  of	  πi,t	  necessitated	  determining	  the	  frequency	  fl,t	  of	  each	  locus	  l	  5 at	  time	  t	  in	  the	  simulation,	  using	  the	  binary	  variables	  gi,l	  that	  represent	  presence	  or	  absence	  6 of	  l	  in	  i:	  7 	  8 
𝑓!,! = 𝑔!,!!!!!!𝑁! 	  	  9 These	  were	  compared	  to	  the	  equilibrium	  frequencies,	  el,	  of	  the	  same	  loci,	  which	  were	  10 assumed	  to	  correspond	  to	  their	  frequencies	  in	  the	  sample	  of	  G0	  genomes	  from	  isolates	  11 sampled	  pre-­‐	  or	  peri-­‐vaccination:	  12 	  13 
𝑒! = 𝑔!,!!!!!!𝐺! 	  	  14 The	  overall	  deviation	  of	  the	  L	  accessory	  genome	  loci	  included	  in	  the	  simulations,	  for	  15 individual	  i	  at	  time	  t,	  πi,t,	  was	  calculated	  as:	  16 	  17 
𝜋!,! = 𝑔!,! 𝑒! − 𝑓!,!!!!! 	  	  18 Therefore	  if	  all	  accessory	  genes	  are	  at	  their	  equilibrium	  frequencies,	  then	   1 + 𝜎! !!,! 	  =	  1,	  19 and	  NFDS	  has	  no	  effect	  on	  an	  individual’s	  reproductive	  fitness.	  When	  a	  genotype	  contains	  20 
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many	  genes	  rarer	  than	  their	  equilibrium	  frequencies,	   1 + 𝜎! !!,! 	  >	  1,	  and	  NFDS	  increases	  an	  1 individual’s	  reproductive	  fitness.	  Lastly,	  when	  a	  genotype	  contains	  many	  genes	  more	  2 common	  than	  their	  equilibrium	  frequencies,	   1 + 𝜎! !!,! 	  <	  1,	  and	  therefore	  NFDS	  reduces	  an	  3 individual’s	  reproductive	  fitness.	  In	  the	  absence	  of	  l	  from	  an	  individual’s	  genotype,	  fl,t	  has	  no	  4 direct	  effect	  on	  its	  fitness.	  5 	  6 
Extension	  to	  heterogeneous	  frequency-­‐dependent	  selection	  7 Two	  further	  parameters	  were	  introduced	  when	  accessory	  genes	  were	  split	  into	  two	  8 categories,	  each	  subject	  to	  a	  different	  level	  of	  frequency	  dependent	  selection.	  The	  σw	  9 parameter	  represented	  the	  strength	  of	  weaker	  NFDS	  acting	  on	  a	  fraction,	  (1-­‐pf),	  of	  the	  10 accessory	  genes	  included	  in	  the	  model.	  To	  facilitate	  inference	  of	  these	  two	  parameters,	  it	  11 was	  assumed	  that	  loci	  under	  weaker	  negative	  frequency	  dependent	  selection	  would	  vary	  in	  12 frequency	  to	  a	  greater	  extent	  between	  the	  initial	  and	  final	  genomic	  samples;	  therefore	  the	  13 accessory	  loci	  were	  ordered	  by	  the	  statistic	  Δl:	  14 	  15 
Δ! = (𝑓!,!!! − 𝑒!)!(1 − 𝑒!(1 − 𝑒!))	  	  16 Where	  el	  is	  the	  frequency	  of	  the	  gCOG	  or	  antibiotic	  resistance	  phenotype	  across	  all	  pre-­‐	  or	  17 peri-­‐vaccination	  samples,	  as	  defined	  previously,	  and	  fl,t>0,	  is	  its	  frequency	  across	  all	  post-­‐18 vaccination	  samples.	  The	  denominator	  is	  intended	  to	  emphasise	  the	  effects	  of	  gCOGs	  at	  19 frequencies	  of	  approximately	  50%,	  which	  are	  likely	  to	  have	  a	  large	  effect	  on	  the	  overall	  20 population	  structure.	  The	  proportion	  pf	  of	  genes	  for	  which	  Δ! 	  was	  smallest	  were	  considered	  21 subject	  to	  NFDS	  with	  strength	  (1+σf),	  whereas	  the	  rest	  where	  subject	  to	  NFDS	  of	  strength	  22 (1+σw).	  If	  the	  L	  loci	  were	  ordered	  by	  ascending	  values	  of	  Δ! ,	  then	  lf	  was	  the	  highest	  ranking	  23 
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meeting	  the	  criterion,	  !!! ≤ 𝑝! .	  This	  resulted	  in	  two	  distinct	  measures	  of	  the	  deviation	  of	  fl,t	  1 from	  el:	  2 	  3 
𝜋!,! = 𝑔!,! 𝑒! − 𝑓!,!!!!!! 	  	  4 And:	  5 
𝜔!,! = 𝑔!,! 𝑒! − 𝑓!,!!!!!!!! 	  	  6 Hence	  the	  modified	  offspring	  distribution	  was:	  7 	  8 
𝑋!,!~𝑃𝑜𝑖𝑠 𝜅𝑁! 1 −𝑚 1 − 𝑣! 1 + 𝜎! !!,! + 1 + 𝜎! !!,! 	  	  9 
Simulations	  and	  parameter	  estimation	  10 The	  model	  was	  implemented	  in	  C++	  using	  the	  GNU	  scientific	  library,	  and	  is	  available	  for	  11 download	  from	  https://github.com/nickjcroucher/multiLocusNFDS.	  In	  each	  simulation,	  12 genotypes	  were	  represented	  by	  the	  gCOGs	  and	  antibiotic	  resistance	  phenotypes	  present	  in	  13 between	  5%	  and	  95%	  of	  the	  pre-­‐	  or	  peri-­‐vaccination	  population.	  Hence	  L	  was	  1,090	  for	  14 Massachusetts,	  1,175	  for	  Southampton,	  1,090	  for	  Nijmegen	  and	  1,254	  for	  Maela.	  For	  15 simplicity,	  κ	  was	  assumed	  to	  represent	  the	  number	  of	  pneumococci	  likely	  to	  transmit	  16 between	  individuals	  in	  the	  sampled	  population.	  This	  was	  estimated	  to	  correspond	  to	  25%	  17 colonisation	  of	  children	  under	  ten	  years	  of	  age	  in	  the	  USA	  and	  European	  samples.	  In	  18 Massachusetts15,	  an	  under	  ten	  population	  of	  828,129	  in	  2000	  82	  implied	  a	  bacterial	  19 population	  size	  of	  2x105	  (105	  was	  actually	  used	  for	  model	  fitting	  for	  computational	  20 
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efficiency;	  comparing	  simulations	  demonstrated	  this	  had	  no	  detectable	  effect	  on	  the	  1 results);	  in	  Southampton	  (including	  Hampshire	  and	  Portsmouth),	  an	  under	  ten	  population	  2 of	  202,404	  in	  201183	  implied	  a	  bacterial	  population	  size	  of	  5x104;	  and	  in	  Nijmegen	  3 (including	  Arnhem),	  an	  under	  ten	  population	  of	  77,753	  in	  201184	  implied	  a	  bacterial	  4 population	  of	  2x104.	  An	  elevated	  colonisation	  rate	  of	  50%85	  was	  used	  for	  Maela,	  where	  5 estimating	  that	  15%	  of	  the	  40,000	  residents	  being	  under	  10	  implied	  a	  bacterial	  population	  6 size	  of	  3x103.	  7 	  8 Each	  simulation	  was	  run	  for	  a	  number	  of	  timesteps	  corresponding	  to	  the	  number	  of	  months	  9 spanned	  by	  the	  genomic	  collection,	  excluding	  early	  or	  late	  years	  in	  which	  sampling	  was	  10 sparse.	  The	  well-­‐sampled	  periods	  were	  the	  72	  months	  between	  spring	  2001	  and	  spring	  11 2007	  for	  Massachusetts50;	  the	  48	  months	  between	  spring	  2007	  and	  spring	  2011	  for	  12 Southampton16;	  the	  120	  months	  between	  2001	  and	  2011	  for	  Nijmegen18;	  and	  the	  24	  months	  13 between	  2007	  and	  2009	  for	  Maela85.	  All	  isolates	  from	  a	  single	  winter	  were	  assigned	  to	  the	  14 year	  in	  which	  the	  season	  ended.	  In	  simulations	  of	  the	  Nijmegen	  population,	  where	  a	  15 substantial	  proportion	  of	  samples	  pre-­‐dated	  the	  vaccine’s	  introduction,	  v	  =	  0	  for	  years	  up	  to	  16 2007.	  In	  each	  case,	  the	  starting	  population	  for	  the	  simulation,	  of	  size	  κ,	  was	  generated	  by	  17 randomly	  resampling	  with	  replacement	  from	  the	  genotypes	  present	  in	  the	  pre-­‐	  and	  peri-­‐18 vaccination	  samples	  in	  each	  study;	  hence	  the	  ‘pre-­‐vaccination’	  population	  consisted	  of	  19 isolates	  sampled	  up	  to	  spring	  2001	  in	  Massachusetts,	  up	  to	  spring	  2007	  in	  Southampton,	  20 and	  up	  to	  2007	  in	  Nijmegen.	  These	  were	  the	  genomic	  samples	  used	  to	  calculate	  el	  for	  all	  21 intermediate	  frequency	  loci;	  all	  later	  samples	  were	  used	  to	  calculate	  fl,t>0	  in	  the	  definition	  of	  22 Δl.	  23 	  24 At	  each	  time	  t	  at	  which	  a	  genomic	  sample	  was	  available,	  the	  equivalent	  number	  of	  25 genotypes	  was	  randomly	  sampled	  from	  the	  simulated	  population.	  The	  similarity	  between	  26 
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the	  simulated	  and	  genomic	  samples	  at	  t	  was	  then	  calculated	  as	  the	  Jensen-­‐Shannon	  1 divergence86	  (JSDt)	  between	  the	  real	  and	  simulated	  samples:	  2 	  3 
𝐽𝑆𝐷! = 12 𝑓!,!,!𝑙𝑛 𝑓!,!,!𝑓!,!,! + 𝑎!,!,! + 12 𝑎!,!,!𝑙𝑛 𝑎!,!,!𝑓!,!,! + 𝑎!,!,!!!!!!!∀! 	  	  4 Where	  ft,s,v	  is	  the	  simulated	  frequency	  of	  genotypes	  of	  sequence	  cluster	  s	  and	  vaccine	  type	  5 status	  v	  at	  time	  t,	  and	  at,s,v	  is	  the	  equivalent	  value	  from	  the	  genomic	  sample.	  This	  value	  was	  6 summed	  over	  all	  vaccine	  type	  statuses	  and	  sequence	  clusters	  for	  each	  timepoint	  sampled	  in	  7 the	  genomic	  dataset	  to	  calculate	  the	  overall	  divergence	  of	  the	  simulation	  from	  the	  sampled	  8 data.	  	  9 	  10 Each	  set	  of	  simulations	  was	  run	  with	  variation	  in	  the	  parameters	  v	  (range	  0-­‐0.5);	  m	  (range	  11 0-­‐0.2);	  σf	  (range	  10-­‐6-­‐0.22);	  σw	  (range	  10-­‐6-­‐0.15;	  only	  in	  the	  heterogeneous	  rates	  model),	  and	  12 
pf	  (range	  0-­‐1;	  only	  in	  the	  heterogeneous	  rates	  model).	  Model	  fitting	  was	  achieved	  through	  13 Approximate	  Bayesian	  Computation	  with	  the	  BOLFI	  algorithm40,	  run	  for	  2,000	  iterations	  of	  14 Bayesian	  optimisation	  to	  identify	  best-­‐fitting	  parameter	  sets	  through	  minimizing	  the	  JSD	  15 (Table	  1	  &	  Supplementary	  Fig	  5).	  Point	  estimates	  of	  parameter	  values	  were	  generated	  16 based	  on	  the	  Gaussian	  process	  minimisers,	  with	  the	  distribution	  of	  the	  projected	  JSD	  values	  17 shown	  for	  each	  fit	  in	  Supplementary	  Fig	  5.	  Exploration	  of	  parameter	  space	  was	  performed	  18 with	  logarithmically	  transformed	  values	  to	  avoid	  discontinuity	  of	  the	  approximate	  19 likelihood	  function	  near	  the	  natural	  boundary	  and	  to	  enable	  better	  fit	  of	  the	  Gaussian	  20 process	  regression.	  The	  95%	  posterior	  credible	  intervals	  for	  the	  parameters	  were	  obtained	  21 using	  three	  generations	  of	  sequential	  Monte	  Carlo	  sampling	  with	  the	  same	  default	  settings	  22 as	  used	  in	  Gutmann	  and	  Corander40	  for	  the	  pneumococcal	  day	  care	  transmission	  model.	  	  23 	  24 
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Alternative	  model	  formulations	  1 To	  test	  whether	  equivalently	  good	  fits	  to	  the	  genomic	  data	  could	  be	  achieved	  using	  different	  2 approaches	  within	  the	  same	  framework,	  alternative	  model	  formulations	  were	  tested.	  The	  3 neutral	  model	  was	  fitted	  in	  the	  same	  way	  as	  the	  multilocus	  NFDS	  models,	  except	  that	  σf	  was	  4 fixed	  at	  zero.	  The	  serotype	  NFDS	  model	  assumed	  all	  serotypes	  were	  present	  at	  equilibrium	  5 frequencies	  in	  the	  pre-­‐vaccine	  samples,	  and	  therefore	  πi,t	  was	  calculated	  as	  the	  deviation	  of	  6 an	  isolate’s	  serotype	  from	  its	  initial	  frequency.	  This	  was	  fitted	  using	  both	  the	  homogeneous	  7 and	  heterogeneous	  selection	  rate	  models.	  In	  the	  latter	  case,	  Δl	  was	  calculated	  by	  comparing	  8 the	  serotype	  el	  values	  with	  their	  post-­‐vaccination	  frequencies,	  as	  for	  the	  intermediate	  9 frequency	  loci.	  The	  same	  parameter	  ranges	  were	  used	  as	  for	  the	  multilocus	  NFDS	  model,	  10 except	  σf	  and	  σw	  were	  allowed	  to	  take	  values	  within	  the	  range	  10-­‐6-­‐25	  to	  compensate	  for	  the	  11 single	  locus	  contributing	  to	  πi,t	  and	  ωi,t.	  Additionally,	  to	  avoid	  many	  lower	  frequency	  12 sequence	  clusters	  evolving	  neutrally,	  serotypes	  were	  considered	  to	  be	  at	  intermediate	  13 frequencies	  if	  they	  were	  between	  1%	  and	  99%	  prevalence	  in	  the	  pre-­‐	  or	  peri-­‐vaccination	  14 population.	  15 	  16 The	  ecotype	  NFDS	  model	  assumed	  each	  sequence	  cluster	  was	  adapted	  to	  a	  specific	  17 ecological	  niche,	  and	  therefore	  was	  present	  at	  an	  equilibrium	  frequency	  in	  the	  pre-­‐vaccine	  18 samples.	  Therefore	  πi,t	  and	  ωi,t	  were	  calculated	  as	  the	  deviation	  of	  an	  isolate’s	  sequence	  19 cluster	  from	  its	  initial	  frequency.	  This	  was	  fitted	  using	  both	  the	  homogeneous	  and	  20 heterogeneous	  selection	  rate	  models	  using	  the	  same	  parameter	  ranges	  and	  intermediate	  21 frequency	  range	  as	  for	  the	  serotype	  NFDS	  model,	  as	  well	  as	  the	  same	  approach	  to	  the	  22 calculation	  of	  Δl.	  For	  both	  the	  serotype	  and	  ecotype	  models,	  fitting	  was	  conducted	  with	  23 BOLFI40	  as	  for	  the	  multilocus	  NFDS	  model,	  using	  JSDs	  to	  quantify	  the	  differences	  between	  24 the	  simulated	  and	  sampled	  populations.	  Results	  are	  shown	  in	  Table	  1.	  These	  25 implementations	  are	  not	  intended	  to	  represent	  the	  optimal	  versions	  of	  each	  model,	  but	  26 
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instead	  demonstrate	  that	  the	  fits	  of	  the	  multilocus	  NFDS	  models	  cannot	  be	  trivially	  1 replicated	  through	  changing	  the	  genetic	  basis	  of	  NFDS.	  2 	  3 Simulations	  in	  which	  isolates	  from	  two	  populations	  were	  combined	  used	  the	  pre-­‐4 vaccination	  population	  from	  Massachusetts	  and	  post-­‐vaccine	  isolates	  from	  one	  of	  the	  5 alternative	  populations.	  The	  initial	  population	  was	  drawn	  only	  from	  Massachusetts;	  both	  6 these	  isolates,	  and	  those	  from	  the	  alternative	  dataset,	  could	  enter	  the	  simulated	  population	  7 through	  migration.	  When	  the	  alternative	  population	  corresponded	  to	  Southampton	  or	  8 Nijmegen,	  the	  population	  size,	  number	  of	  generations,	  parameter	  point	  estimates,	  Δl	  and	  el	  9 values	  were	  those	  of	  the	  alternative	  population.	  When	  the	  alternative	  population	  was	  Maela,	  10 the	  el	  and	  Δl	  values	  were	  those	  of	  the	  alternative	  population,	  but	  the	  simulations	  were	  11 otherwise	  parameterised	  for	  the	  Massachusetts	  population,	  due	  to	  the	  difficulty	  of	  obtaining	  12 robust	  point	  estimates	  for	  parameters	  from	  the	  Maela	  population	  as	  a	  consequence	  of	  the	  13 lack	  of	  vaccine	  introduction	  in	  this	  location.	  	  14 	  15 
Statistical	  analyses	  16 Statistical	  analyses,	  including	  calculation	  of	  Pearson’s	  R2,	  Wilcoxon	  tests,	  interquartile	  17 ranges	  and	  Fisher’s	  exact	  tests,	  were	  performed	  in	  R87.	  Estimation	  of	  parameter	  values	  and	  18 credibility	  intervals	  through	  model	  fitting	  were	  performed	  with	  BOLFI40.	  All	  reported	  p	  19 values	  are	  two-­‐sided.	  20 	  21 
Code	  availability	  22 The	  model	  code	  used	  in	  this	  analysis	  is	  freely	  available	  from	  the	  GitHub	  repository,	  23 https://github.com/nickjcroucher/multilocusNFDS.	  24 	  25 
Data	  availability	  26 
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The	  sequence	  datasets	  analysed	  in	  the	  current	  study	  are	  available	  in	  the	  public	  sequence	  1 databases	  with	  the	  accession	  codes	  listed	  in	  Supplementary	  Dataset	  3.	  The	  epidemiological	  2 and	  phylogenetic	  data	  analysed	  in	  the	  current	  study	  are	  available	  from	  3 https://microreact.org/project/multilocusNFDS.	  	  4 	  5 
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Figure	  1.	  Diversity	  and	  structure	  of	  the	  pneumococcal	  population.	  a	  Functional	  1 classification	  of	  the	  1,112	  intermediate-­‐frequency	  and	  1,194	  core	  COGs	  in	  the	  2 Massachusetts	  pneumococcal	  population,	  as	  detailed	  in	  Supplementary	  Datasets	  1	  and	  2.	  3 Each	  barchart	  compares	  the	  frequencies	  of	  functional	  categories	  in	  intermediate-­‐frequency	  4 and	  core	  COGs.	  Categories	  are	  grouped	  as	  likely	  to	  be	  under	  NFDS	  resulting	  from	  bacterium-­‐5 MGE	  interactions	  (pink	  segments),	  bacterium-­‐bacterium	  interactions	  (blue	  segments),	  or	  6 bacterium-­‐host	  interactions	  (green	  segments).	  The	  chart	  with	  orange	  segments	  shows	  the	  7 frequencies	  of	  loci	  with	  roles	  in	  general	  metabolism	  or	  signal	  transduction,	  or	  otherwise	  8 could	  not	  be	  classified.	  b	  Population	  structure	  of	  the	  4,127	  isolates	  from	  Massachusetts	  9 (Mass),	  Southampton	  (Soton),	  Nijmegen	  and	  Maela	  (Supplementary	  Dataset	  3).	  The	  10 maximum	  likelihood	  phylogeny	  was	  generated	  from	  1,447	  core	  gCOGs.	  The	  adjacent	  11 columns	  contain	  a	  row	  for	  each	  genome,	  which	  represent	  the	  population	  in	  which	  the	  12 bacterium	  was	  isolated,	  its	  susceptibility	  to	  PCV7-­‐induced	  immunity,	  and	  sequence	  cluster	  13 classification.	  c	  Comparison	  of	  core	  genome	  divergence,	  quantified	  as	  the	  cophenetic	  14 distance	  between	  isolates	  in	  the	  core	  genome	  phylogeny,	  and	  the	  accessory	  genome	  15 divergence,	  quantified	  as	  the	  Jaccard	  distance	  between	  the	  gCOG	  content	  of	  isolates.	  Each	  16 point	  is	  a	  pairwise	  comparison	  between	  randomly	  sampled	  isolates	  (excluding	  the	  17 polyphyletic	  SC0),	  which	  was	  coloured	  orange	  if	  the	  isolates	  belonged	  to	  the	  same	  sequence	  18 cluster;	  purple	  if	  they	  belonged	  to	  different	  sequence	  clusters	  but	  were	  both	  encapsulated;	  19 or	  otherwise	  dark	  blue,	  revealing	  the	  presence	  of	  some	  genetically	  divergent	  20 unencapsulated	  genotypes.	  Isocontour	  lines	  quantify	  the	  distribution	  of	  points	  in	  each	  21 category.	  22 	   	  23 
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Figure	  2.	  Distribution	  of	  genetic	  diversity	  between	  populations.	  Column	  (a)	  compares	  the	  1 distribution	  of	  sequence	  clusters	  between	  populations;	  the	  frequency	  of	  each	  sequence	  2 cluster	  in	  Massachusetts	  is	  shown	  on	  the	  horizontal	  axis,	  and	  the	  corresponding	  frequencies	  3 in	  Maela,	  Southampton	  and	  Nijmegen	  are	  shown	  on	  the	  vertical	  axes	  in	  the	  plots	  from	  top	  to	  4 bottom.	  Red	  points	  correspond	  to	  predominantly	  VT	  (≥75%)	  sequence	  clusters;	  blue	  points	  5 to	  predominantly	  NVT	  (≥75%)	  sequence	  clusters,	  and	  black	  points	  to	  mixed	  sequence	  6 clusters.	  Column	  (b)	  compares	  the	  distribution	  of	  gCOGs	  between	  populations.	  The	  7 frequency	  of	  each	  in	  Massachusetts	  is	  shown	  on	  the	  horizontal	  axis,	  and	  the	  corresponding	  8 frequencies	  in	  Maela,	  Southampton	  and	  Nijmegen	  are	  shown	  on	  the	  vertical	  axes.	  Only	  9 gCOGs	  present	  at	  a	  mean	  frequency	  between	  5%	  and	  95%	  across	  the	  two	  compared	  10 populations	  were	  included,	  and	  the	  corresponding	  points	  are	  coloured	  according	  to	  the	  11 functional	  annotation	  of	  COGs	  in	  Fig	  1a.	  The	  elevated	  frequencies	  of	  gCOGs	  encoded	  by	  12 Tn916,	  including	  the	  tetM	  tetracycline	  resistance	  gene,	  in	  Maela	  are	  annotated.	  Column	  (c)	  13 compares	  the	  pre-­‐	  and	  post-­‐vaccination	  frequencies	  of	  sequence	  clusters	  in	  Massachusetts,	  14 Southampton	  and	  Nijmegen.	  Points	  are	  coloured	  as	  in	  (a),	  showing	  the	  general	  decline	  in	  15 the	  frequency	  of	  VT	  sequence	  clusters.	  Column	  (d)	  compares	  the	  pre-­‐	  and	  post-­‐vaccination	  16 frequency	  of	  gCOGs	  in	  Massachusetts,	  Southampton	  and	  Nijmegen.	  Only	  gCOGs	  with	  an	  17 overall	  frequency	  between	  5%	  and	  95%	  in	  the	  relevant	  population	  were	  included	  in	  the	  18 panels.	  Points	  are	  coloured	  as	  in	  (b).	  The	  reduced	  frequency	  of	  the	  wciN	  allele	  involved	  in	  19 synthesis	  of	  the	  VT	  6A	  and	  6B	  capsules	  is	  annotated.	  As	  the	  relationships	  between	  gCOG	  20 frequencies	  were	  linear,	  each	  panel	  displays	  Pearson’s	  correlation	  statistics,	  including	  two-­‐21 sided	  p	  values.	  22 	   	  23 
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Figure	  3.	  Comparing	  the	  sampled	  and	  simulated	  pneumococcal	  populations.	  In	  each	  2 barplot,	  the	  bacterial	  population	  is	  split	  into	  sequence	  clusters	  by	  vertical	  black	  lines,	  3 annotated	  at	  the	  top	  of	  the	  graph.	  Each	  sequence	  cluster	  is	  split	  into	  three	  timepoints:	  pre-­‐4 vaccination,	  a	  midpoint	  sample	  and	  a	  late	  sample.	  Only	  sequence	  clusters	  present	  at	  greater	  5 than	  2.5%	  frequency	  at	  one	  of	  these	  timepoints	  in	  the	  genomic	  sample	  are	  included	  in	  the	  6 graphs;	  full	  results	  are	  shown	  in	  the	  supplementary	  materials.	  The	  bars	  at	  each	  timepoint	  7 are	  split	  into	  red	  segments,	  for	  VT	  isolates,	  and	  blue	  segments,	  for	  NVT	  isolates.	  In	  each	  8 comparison,	  the	  top	  row	  is	  the	  genomic	  sample	  against	  which	  simulations	  were	  evaluated.	  9 The	  bottom	  row	  summarises	  the	  output	  of	  100	  simulations	  using	  the	  heterogeneous	  rate	  10 
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multilocus	  NFDS	  model	  performed	  using	  the	  point	  estimate	  parameter	  values	  from	  Table	  1.	  1 At	  the	  times	  at	  which	  samples	  were	  present	  in	  the	  respective	  genomic	  collections,	  the	  same	  2 numbers	  of	  isolates	  were	  randomly	  selected	  from	  the	  simulated	  populations.	  The	  bars	  3 represent	  the	  median	  result,	  and	  the	  error	  bars	  (orange	  for	  VT	  isolates,	  and	  purple	  for	  NVT	  4 isolates)	  represent	  the	  interquartile	  range	  observed	  across	  the	  simulations.	  (a)	  The	  results	  5 for	  Massachusetts	  split	  isolates	  into	  pre-­‐vaccination	  (2001;	  133	  isolates),	  midpoint	  (2004;	  6 203	  isolates)	  and	  late	  (2007;	  280	  isolates)	  samples.	  (b)	  The	  results	  for	  Southampton,	  7 splitting	  isolates	  into	  pre-­‐vaccination	  (up	  to	  2007;	  100	  isolates),	  midpoint	  (2008-­‐2009;	  194	  8 isolates)	  and	  late	  (2010-­‐2011;	  195	  isolates)	  samples.	  (c)	  The	  results	  for	  Nijmegen,	  splitting	  9 isolates	  into	  pre-­‐vaccination	  (up	  to	  2007;	  209	  isolates),	  midpoint	  (2008-­‐2009;	  80	  isolates)	  10 and	  late	  (2010-­‐2011;	  48	  isolates)	  samples.	  11 	  12 
	   	  13 
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Table	  1.	  Parameter	  estimates	  from	  model	  fits	  achieved	  through	  Approximate	  Bayesian	  4 Computation	  with	  BOLFI,	  run	  for	  2,000	  iterations.	  The	  displayed	  values	  represent	  point	  5 estimates	  of	  parameters	  generated	  based	  on	  the	  Gaussian	  process	  minimisers,	  with	  95%	  6 credibility	  intervals	  in	  parentheses	  where	  calculated.	  The	  simplest	  neutral	  model	  required	  7 fitting	  only	  v	  and	  m	  to	  the	  genomic	  data.	  Homogeneous	  rate	  (σf,	  v	  and	  m)	  and	  heterogeneous	  8 rate	  (σf,	  v,	  m,	  pf	  	  and	  σw)	  fits	  are	  shown	  for	  the	  multilocus	  NFDS	  model,	  in	  which	  9 
 - 46 - 
intermediate	  frequency	  gCOGs	  and	  resistance	  phenotypes	  have	  equilibrium	  frequencies;	  for	  1 the	  serotype	  NFDS	  model,	  in	  which	  serotypes	  have	  equilibrium	  frequencies;	  and	  for	  the	  2 ecotype	  model,	  in	  which	  sequence	  clusters	  have	  equilibrium	  frequencies.	  Replicate	  fits	  of	  3 the	  heterogeneous	  rate	  multilocus	  NFDS	  models	  to	  the	  Massachusetts,	  Southampton	  and	  4 Nijmegen	  datasets	  are	  shown	  in	  Supplementary	  Table	  1	  to	  demonstrate	  the	  robustness	  of	  5 the	  fitting	  process	  to	  stochastic	  effects.	  6 	  7 
